| Application no. and date | 16723107.5 (espacenet) (Federated) (European Patent Register), 20160516 |
| Patent/reg. no. and date | DK/EP 3297631, 20190904 |
| Publication date | 20180328 |
| Priority no. and date | US 201562162870 P, 20150518 |
| EP pub. no. and date |
EP 3297631 20180328 |
| Effective date | |
| Applicant/owner | KaNDy Therapeutics Limited, 400 South Oak Way
Reading, Berkshire RG2 6AD, GB |
| Applicant ref. no. | P171446.DK.01/FENTONJ/LJUNGBERGR |
| Inventor | TROWER, Mike, c/o NeRRe Therapeutics Limited Stevenage
Bioscience Cat. Incub. Bldg. Gunnels
Wood Road
Stevenage
Hertfordshire SG1 2FX, GB |
| Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI |
| Opponent | |
| IPC Class | A61K 31/5383 (2006.01) , A61P 43/00 (2006.01) , A61P 5/24 (2006.01) |
| Title | NK-1/NK-3-receptorantagonist til behandling af hedeture |
| Int. application no. | EP2016060945 |
| Int. publication no. | WO2016184829 |
| Related patent (certificate) | CA 2026 00007 |
| Status | DK/EP patent |
| Pædiatrisk forlængelse | - |
| Udløbsdato for pædiatrisk forlængelse | - |
